Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley H Appel

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Brain, Behavior, & Immunity - Health|September 30, 2021
Serum programmed cell death proteins in amyotrophic lateral sclerosisDavid R Beers, Weihua Zhao, Jason R Thonhoff, et al.
Biochemical and Biophysical Research Communications|March 7, 2006
Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's diseaseIra L Goldknopf, Essam A Sheta, Jennifer Bryson, et al.
Annals of Clinical and Translational Neurology|April 7, 2026
Longitudinal Assessment of Biomarkers in ALS: Discriminative Biomarkers for Disease Progression and SurvivalDavid R Beers, Yueh-Yun Lin, Jason R Thonhoff, et al.
Frontiers in Neurology|June 25, 2024
A phase 1 proof-of-concept study evaluating safety, tolerability, and biological marker responses with combination therapy of CTLA4-Ig and interleukin-2 in amyotrophic lateral sclerosisJason R Thonhoff, David R Beers, Weihua Zhao, et al.
Brain Research|September 8, 2019
Phenotypic characteristics of human bone marrow-derived endothelial progenitor cells in vitro support cell effectiveness for repair of the blood-spinal cord barrier in ALSSvitlana Garbuzova-Davis, Jared Ehrhart, Hilmi Mustafa, et al.
Brain Communications|September 21, 2020
Restoring regulatory T-cell dysfunction in Alzheimer's disease through <i>ex vivo</i> expansionAlireza Faridar, Aaron D Thome, Weihua Zhao, et al.
Journal of Neuropathology and Experimental Neurology|May 19, 2017
Clinical Significance of TDP-43 Neuropathology in Amyotrophic Lateral SclerosisMatthew D Cykowski, Suzanne Z Powell, Leif E Peterson, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 31, 2018
Expanded autologous regulatory T-lymphocyte infusions in ALS: A phase I, first-in-human studyJason R Thonhoff, David R Beers, Weihua Zhao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 20, 2018
Head-to-Head Comparison of <sup>11</sup>C-PBR28 and <sup>18</sup>F-GE180 for Quantification of the Translocator Protein in the Human BrainPaolo Zanotti-Fregonara, Belen Pascual, Gaia Rizzo, et al.
Scientific Reports|September 18, 2020
Elevated acute phase proteins reflect peripheral inflammation and disease severity in patients with amyotrophic lateral sclerosisDavid R Beers, Weihua Zhao, Daniel W Neal, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Brain, Behavior, & Immunity - Health|September 30, 2021
Serum programmed cell death proteins in amyotrophic lateral sclerosisDavid R Beers, Weihua Zhao, Jason R Thonhoff, et al.
Biochemical and Biophysical Research Communications|March 7, 2006
Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's diseaseIra L Goldknopf, Essam A Sheta, Jennifer Bryson, et al.
Annals of Clinical and Translational Neurology|April 7, 2026
Longitudinal Assessment of Biomarkers in ALS: Discriminative Biomarkers for Disease Progression and SurvivalDavid R Beers, Yueh-Yun Lin, Jason R Thonhoff, et al.
Frontiers in Neurology|June 25, 2024
A phase 1 proof-of-concept study evaluating safety, tolerability, and biological marker responses with combination therapy of CTLA4-Ig and interleukin-2 in amyotrophic lateral sclerosisJason R Thonhoff, David R Beers, Weihua Zhao, et al.
Brain Research|September 8, 2019
Phenotypic characteristics of human bone marrow-derived endothelial progenitor cells in vitro support cell effectiveness for repair of the blood-spinal cord barrier in ALSSvitlana Garbuzova-Davis, Jared Ehrhart, Hilmi Mustafa, et al.
Brain Communications|September 21, 2020
Restoring regulatory T-cell dysfunction in Alzheimer's disease through <i>ex vivo</i> expansionAlireza Faridar, Aaron D Thome, Weihua Zhao, et al.
Journal of Neuropathology and Experimental Neurology|May 19, 2017
Clinical Significance of TDP-43 Neuropathology in Amyotrophic Lateral SclerosisMatthew D Cykowski, Suzanne Z Powell, Leif E Peterson, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 31, 2018
Expanded autologous regulatory T-lymphocyte infusions in ALS: A phase I, first-in-human studyJason R Thonhoff, David R Beers, Weihua Zhao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 20, 2018
Head-to-Head Comparison of <sup>11</sup>C-PBR28 and <sup>18</sup>F-GE180 for Quantification of the Translocator Protein in the Human BrainPaolo Zanotti-Fregonara, Belen Pascual, Gaia Rizzo, et al.
Scientific Reports|September 18, 2020
Elevated acute phase proteins reflect peripheral inflammation and disease severity in patients with amyotrophic lateral sclerosisDavid R Beers, Weihua Zhao, Daniel W Neal, et al.
Pageof 10